Thanks to Sonia Ike for her excellent presentation on paediatric sarcoma.
Here is a presentation from Dr Sirke Rinkoff about giant cell tumour of bone and aneurysmal bone cysts as given at an RNOH teaching session on 3rd May 2018.
Here is a brief overview of Ewings Sarcoma from Loukas Andritsos.
Here is an excellent summary of chondrosarcoma from Ali Najefi.
Thanks to Alex Liddle for this excellent presentation discussing how to critique a scientific paper.
Myositis ossificans (MO) and fibro-osseous pseudotumour of digits are localised self-limiting lesions composed of reactive hypercellular fibrous tissue and bone (1). They often grow rapidly and biopsy may reveal mitotic activity and hypercellularity, and they are therefore classic pseudosarcomas.
These conditions can occur throughout life, but are most common in young adulthood (mean age 32 years). Males are more frequently affected than females (3:2), although FP more commonly occurs in females.
Soft tissue injury is the most common initiating event. MO can develop anywhere in the body but is most common in areas which are readily injured, such as the extremities, thigh, buttock and shoulder. It usually develops in skeletal muscle. Similar lesions occur in the subcutaneous tissue (panniculitis ossificans), tendons or fascia (fasciitis ossificans).
Early in the development of the lesion, there is classically swelling and pain. Calcification appears after 2-6 weeks, often in an eggshell like-distribution (hence the synonym myositis ossificans circumscripta). Over time, lesions become hard and well demarcated.
Lesions range in size from 2 to 12cm with a mean of around 5cm. Macroscopically they have a gritty white periphery and a soft tan haemorrhagic centre. On microscopy, early lesions appear highly cellular, comprising proliferating fibroblasts. There can be well-formed bony trabeculae peripherally.
Treatment is usually expectant with anti-inflammatory medication. Lesions can be removed after they have matured. Recurrence is unusual. The use of bisphosphonates has been described (2).
1. WHO Classification of tumours of soft tissue and bone. 4th Edition. 2013
2. Mani-Babu S et al. Quadriceps traumatic myositis ossificans in a football player: management with intravenous pamidronate. Clin J Sport Med. 2014 Sep;24(5):e56-8
Sacrectomy is a challenging surgical procedure used in the treatment of primary tumours of the sacrum (eg chordoma) or rectal tumours (usually locally recurrent) involving the sacrum. The complexity and disability associated with the procedure depends in large part on the level of resection. High sacral resections can lead to loss of bladder and bowel function (1).
The procedure can be performed through a combined abdomino-lateral approach, sequential abdominal then posterior approaches or entirely by a posterior approach depending on the local extent of the tumour and involvement of critical anatomical structures. Division of the bone just below the lower border of S3 preserves sphincteric function. Bilateral sacrifice of S2-S4 roots lead to urinary and faecal incontinence and male impotence. Anorectal incontinence can be preserved if one S2 root is maintained.
The dural sac ends at the S2/3 junction, and if entered, requires meticulous closure. For higher sacral resections the posterior sacral plate is removed with rongeurs, which may allow identification of sacral nerve roots. Attempts should be made to spare the pudendal nerve if it is encountered running posterior to the ischial spine.
Sacrectomy requires specialist expertise and a team which includes colorectal, orthopaedic and plastic surgical expertise as appropriate. After resection of the sacrum, reconstruction of the soft tissue defect may be achieved using a VRAM rectus abdominis pedicled flap or IGAP gluteal muscle transfers.
For more information, the chapter on sacrectomy in Malawer’s book is very helpful (http://www.sarcoma.org/publications/mcs/ch27.pdf).
1. Spine J. 2015 Feb 1;15(2):222-9. Maintenance of bowel, bladder, and motor functions after sacrectomy. Moran D, Zadnik PL, Taylor T, Groves ML, Yurter A, Wolinsky JP, Witham TF, Bydon A, Gokaslan ZL, Sciubba DM.